Francesco Panzuto | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: a comparison between pancreatic and gastrointestinal localizations	PANCREATOLOGY	2019
The ENETS TNM staging and grading system accurately predict prognosis in patients with rectal NENs	DIGESTIVE AND LIVER DISEASE	2019
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms. Data from a large international cohort study	NEUROENDOCRINOLOGY	2019
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: a real-world study	PANCREATOLOGY	2018
Heterogeneity of duodenal neuroendocrine tumors: an Italian multi-center experience	ANNALS OF SURGICAL ONCOLOGY	2018
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues	GASTROENTEROLOGY	2018
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors	ENDOCRINE-RELATED CANCER	2018
Clinical Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine Neoplasms	THE ONCOLOGIST	2018
Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors – a multi-institutional study	HPB	2018
Therapy for Locoregional Disease. Stomach/Duodenum, Colon/Rectum	Neuroendocrine Tumors in Real Life	2018
Evaluation of the relationships between computed tomography features, pathological findings, and rrognostic risk assessment in gastrointestinal stromal tumors	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY	2017
Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms	PLOS ONE	2017
Functional imaging in the follow-up of enteropancreatic neuroendocrine tumors: Clinical usefulness and indications	THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM	2017
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives	JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY	2017
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors	CANCER MEDICINE	2017
Lack of association for reported endocrine pancreatic cancer risk Loci in the PANDoRA consortium	CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION	2017
Stage IV gastro-entero-pancreatic neuroendocrine neoplasms. A risk score to predict clinical outcome	THE ONCOLOGIST	2017
Everolimus in pancreatic neuroendocrine carcinomas G3	PANCREAS	2017
Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors. a systematic review and meta-analysis	ONCOTARGET	2017
A case of pancreatic small cell neuroendocrine carcinoma associated with SIADH	PANCREAS	2016